Muhammed Kizilgul is an expert in Endocrinology at Ankara Etlik City Hospital (Turkey). Muhammed Kizilgul has authored 146 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 384 (community average: 125). How the SLR is computed.

LeadR Profile

Muhammed Kizilgul Ankara Etlik City Hospital Turkey
384 ScienceLeadR Reputation 384
Network Map

Endocrinology

Subspecialties: Biochemistry - Oncology - Otolaryngology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2015 - 2026

Source: PubMed

University of Minnesota

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 146

Citations

Citations: 2 953 1st author: 30 Last author: 15 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Metabolic dysfunction-associated steatotic liver disease in Cushing's syndrome: prevalence, determinants, and changes after remission.
PMID 42109743 — liver diseases, fibrosis, liver, prevalence, hydrocortisone, endocrine system diseases, cushing syndrome
Front Endocrinol (Lausanne)20260
Increased prevalence of abdominal aortic aneurysm in biochemically confirmed primary aldosteronism: a new complication?
PMID 42081031 — aortic aneurysm, aneurysm, hyperaldosteronism, hormones, prevalence, endocrine system diseases, aortic aneurysm, abdominal
Endocrine20260
Gonadal recovery in men with prolactinomas on cabergoline: 6-month testosterone levels as a predictor of testosterone replacement timing.
PMID 41926073 — hypogonadism, prolactinoma, neoplasms, recycling, cabergoline, hormones, testosterone, therapeutics
Hormones (Athens)20260
Identification of High-Risk Individuals for Osteoporosis and Fragility Fractures in Cushing's Syndrome: A Promising Predictive Approach.
PMID 41899363 — diabetes mellitus, osteoporosis, hydrocortisone, cushing syndrome
J Clin Med20260
Reevaluating the Need for Routine IGF-1 Screening in Poorly Controlled Type 2 Diabetes Mellitus.
PMID 41878803 — diabetes mellitus, growth, insulin, acromegaly, growth hormone, insulin-like growth factor i, diabetes mellitus, type 2
Endocrinol Diabetes Metab20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map